Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Glycoengineered CD20 antibody obinutuzumab activates neutrophils and mediates phagocytosis through CD16B more efficiently than rituximab
Josée Golay, Fabio Da Roit, Luca Bologna, et al.
Blood (2013) Vol. 122, Iss. 20, pp. 3482-3491
Open Access | Times Cited: 211

Showing 1-25 of 211 citing articles:

Phagocytosis checkpoints as new targets for cancer immunotherapy
Mingye Feng, Wen Jiang, Betty Y.S. Kim, et al.
Nature reviews. Cancer (2019) Vol. 19, Iss. 10, pp. 568-586
Open Access | Times Cited: 744
Fc glycans of therapeutic antibodies as critical quality attributes
Dietmar Reusch, Max L. Tejada
Glycobiology (2015) Vol. 25, Iss. 12, pp. 1325-1334
Open Access | Times Cited: 353
Current progress in innovative engineered antibodies
William R. Strohl
Protein & Cell (2017) Vol. 9, Iss. 1, pp. 86-120
Open Access | Times Cited: 252
Fc-Galactosylation of Human Immunoglobulin Gamma Isotypes Improves C1q Binding and Enhances Complement-Dependent Cytotoxicity
Benjamin Peschke, Christian W. Keller, Patrick Weber, et al.
Frontiers in Immunology (2017) Vol. 8
Open Access | Times Cited: 192
Mechanisms of disease: The human N-glycome
Gordan Lauc, Marija Pezer, Igor Rudan, et al.
Biochimica et Biophysica Acta (BBA) - General Subjects (2015) Vol. 1860, Iss. 8, pp. 1574-1582
Open Access | Times Cited: 180
Neutrophils in cancer
Louise W. Treffers, Ida H. Hiemstra, Taco W. Kuijpers, et al.
Immunological Reviews (2016) Vol. 273, Iss. 1, pp. 312-328
Open Access | Times Cited: 173
Expression, Role, and Regulation of Neutrophil Fcγ Receptors
Yu Wang, Friederike Jönsson
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 149
B cells in the tumor microenvironment: Multi-faceted organizers, regulators, and effectors of anti-tumor immunity
Céline M. Laumont, Brad H. Nelson
Cancer Cell (2023) Vol. 41, Iss. 3, pp. 466-489
Open Access | Times Cited: 91
Smad3 is essential for polarization of tumor-associated neutrophils in non-small cell lung carcinoma
Jeff Yat‐Fai Chung, Philip Chiu‐Tsun Tang, Max Kam‐Kwan Chan, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 49
B-cell depletion in autoimmune diseases
Georg Schett, György Nagy, Gerhard Krönke, et al.
Annals of the Rheumatic Diseases (2024), pp. ard-225727
Closed Access | Times Cited: 16
The immunoglobulin G1 N-glycan composition affects binding to each low affinity Fc γ receptor
Ganesh P. Subedi, Adam W. Barb
mAbs (2016) Vol. 8, Iss. 8, pp. 1512-1524
Open Access | Times Cited: 163
A tale of two antibodies: obinutuzumab versus rituximab
Ciara L. Freeman, Laurie H. Sehn
British Journal of Haematology (2018) Vol. 182, Iss. 1, pp. 29-45
Open Access | Times Cited: 154
Obinutuzumab induces superior B-cell cytotoxicity to rituximab in rheumatoid arthritis and systemic lupus erythematosus patient samples
Venkat Reddy, Christian Klein, David Isenberg, et al.
Lara D. Veeken (2017) Vol. 56, Iss. 7, pp. 1227-1237
Open Access | Times Cited: 150
Therapeutic Antibodies: What Have We Learnt from Targeting CD20 and Where Are We Going?
Michael J. Marshall, Richard J. Stopforth, Mark S. Cragg
Frontiers in Immunology (2017) Vol. 8
Open Access | Times Cited: 150
Ibrutinib interferes with the cell-mediated anti-tumor activities of therapeutic CD20 antibodies: implications for combination therapy
Fabio Da Roit, Patrick Engelberts, Ronald P. Taylor, et al.
Haematologica (2014) Vol. 100, Iss. 1, pp. 77-86
Open Access | Times Cited: 145
Glycoengineering of Therapeutic Antibodies Enhances Monocyte/Macrophage-Mediated Phagocytosis and Cytotoxicity
Sylvia Herter, Martina Birk, Christian Klein, et al.
The Journal of Immunology (2014) Vol. 192, Iss. 5, pp. 2252-2260
Open Access | Times Cited: 136
Therapeutic monoclonal antibody N-glycosylation – Structure, function and therapeutic potential
Florian Cymer, Hermann Beck, Adelheid Rohde, et al.
Biologicals (2017) Vol. 52, pp. 1-11
Closed Access | Times Cited: 123
A randomized, open-label, Phase III study of obinutuzumab or rituximab plus CHOP in patients with previously untreated diffuse large B-Cell lymphoma: final analysis of GOYA
Laurie H. Sehn, Maurizio Martelli, Marek Trnĕný, et al.
Journal of Hematology & Oncology (2020) Vol. 13, Iss. 1
Open Access | Times Cited: 120
Boosting therapeutic potency of antibodies by taming Fc domain functions
Tae Hyun Kang, Sang Taek Jung
Experimental & Molecular Medicine (2019) Vol. 51, Iss. 11, pp. 1-9
Open Access | Times Cited: 111
Advances in targeted therapy for malignant lymphoma
Li Wang, Wei Qin, Yujia Huo, et al.
Signal Transduction and Targeted Therapy (2020) Vol. 5, Iss. 1
Open Access | Times Cited: 102
A potent human neutralizing antibody Fc-dependently reduces established HBV infections
Dan Li, Wenhui He, Ximing Liu, et al.
eLife (2017) Vol. 6
Open Access | Times Cited: 101
Dimeric FcγR Ectodomains as Probes of the Fc Receptor Function of Anti-Influenza Virus IgG
Bruce D. Wines, Hillary A. Vanderven, Sandra Esparon, et al.
The Journal of Immunology (2016) Vol. 197, Iss. 4, pp. 1507-1516
Open Access | Times Cited: 99
Human neutrophils mediate trogocytosis rather than phagocytosis of CLL B cells opsonized with anti-CD20 antibodies
Rut Valgardsdottir, Irene Cattaneo, Christian Klein, et al.
Blood (2017) Vol. 129, Iss. 19, pp. 2636-2644
Closed Access | Times Cited: 98
Anti-CD20 monoclonal antibodies: reviewing a revolution
Joshua Casan, Jonathan Wong, Melissa Northcott, et al.
Human Vaccines & Immunotherapeutics (2018) Vol. 14, Iss. 12, pp. 2820-2841
Open Access | Times Cited: 94
FcγRIIIb Restricts Antibody-Dependent Destruction of Cancer Cells by Human Neutrophils
Louise W. Treffers, Michel van Houdt, Christine W. Bruggeman, et al.
Frontiers in Immunology (2019) Vol. 9
Open Access | Times Cited: 94
Page 1 - Next Page

Scroll to top